TransEnterix (San Diego, CA) a clinical-stage medical device company focused on laparoscopic systems for abdominal surgery, closed a $15M Series B financing. Participants include Aisling Capital, Quaker BioVentures, Intersouth Partners, Synergy Life Science Partners and SV Life Sciences.